Ignite Creation Date:
2024-05-06 @ 10:51 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03377491
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-04-10
First Post:
2017-12-06
Brief Title:
Effect of Tumor Treating Fields TTFields 150 kHz as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel PANOVA-3
Sponsor:
NovoCure Ltd
Organization:
NovoCure Ltd
Organization Data
Organization:
NovoCure Ltd
Class:
INDUSTRY
Study ID:
EF-27
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NovoCure Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None